ScotBio is delighted to be included in the Maritime Forum as one of the top prospects for Blue Growth in Europe. Driven by the European Maritime and Fisheries Fund, BlueInvest works to boost innovation in sustainable technologies for the blue economy by showcasing early-stage businesses, SMEs and scale-ups for investment.
ScotBio is expanding its R&D programme to explore the potential of cyanobacteria to treat emerging viral pathogens, including coronaviruses. With funding from Medical Research Scotland, a new collaborative partnership with Infection Medicine at the University of Edinburgh will investigate how cyanobacterial extracts, recognized previously for their antiviral activity, can be commercially mass produced using ScotBio’s established production processes and used in the treatment of major emerging viral diseases.
